Angion Biomedica Corp.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public, Subsidiary
- Established
- 1998-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.angion.com
Study to Evaluate the Safety and Activity of BB3 to Treat Heart Attack
- First Posted Date
- 2012-02-27
- Last Posted Date
- 2014-11-21
- Lead Sponsor
- Angion Biomedica Corp
- Target Recruit Count
- 5
- Registration Number
- NCT01539590
- Locations
- 🇺🇸
Yale University Medical Center, New Haven, New York, United States
🇺🇸Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, United States
Study to Improve Renal Function After Kidney Transplantation
- First Posted Date
- 2011-01-31
- Last Posted Date
- 2015-05-05
- Lead Sponsor
- Angion Biomedica Corp
- Target Recruit Count
- 30
- Registration Number
- NCT01286727
- Locations
- 🇺🇸
Medstar Georgetown University Hospital, Washington, District of Columbia, United States
🇺🇸Division of Transplant Surgery, University of Maryland School of Medicine, University of Maryland Medical Center, Baltimore, Maryland, United States
🇺🇸California Institute of Renal Research, San Diego, California, United States
© Copyright 2025. All Rights Reserved by MedPath